[HTML] sciencedirect.com

[HTML][HTML] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux, LD Locati… - Annals of …, 2022 - Elsevier
Between 2013 and 2015, a number of multikinase inhibitors (MKIs) targeting the vascular
endothelial growth factor receptor (VEGFR) were approved by the European Medicines …
被引用次数：66 相关文章

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl… - Annals of oncology …, 2022 - pubmed.ncbi.nlm.nih.gov
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid
cancer ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced …
[HTML] annalsofoncology.org

[HTML][HTML] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux… - Annals of …, 2022 - annalsofoncology.org
Between 2013 and 2015, a number of multikinase inhibitors (MKIs) targeting the vascular
endothelial growth factor receptor (VEGFR) were approved by the European Medicines …
[PDF] lmu-klinikum.de

[PDF][PDF] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux, LD Locati… - cdn.lmu-klinikum.de
Between 2013 and 2015, a number of multikinase inhibitors (MKIs) targeting the vascular
endothelial growth factor receptor (VEGFR) were approved by the European Medicines …

[引用][C] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux… - ANNALS OF …, 2022 - iris.uniroma1.it
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid
cancer IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …

[引用][C] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux… - ANNALS OF …, 2022 - iris.unito.it
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced
thyroid cancer IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie …
[PDF] scrvt.com

[PDF][PDF] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux, LD Locati… - cdn0.scrvt.com
Between 2013 and 2015, a number of multikinase inhibitors (MKIs) targeting the vascular
endothelial growth factor receptor (VEGFR) were approved by the European Medicines …

[引用][C] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux… - ANNALS OF …, 2022 - iris.unibs.it
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid
cancer IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste IT Italiano …

[引用][C] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.

S Filetti, C Durante, DM Hartl, S Leboulleux… - Annals of Oncology …, 2022 - europepmc.org
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced
thyroid cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …